Robb Gary Charles

Corcept Therapeutics Incorporated · Chief Business Officer

Robb Gary Charles is listed in public filings as officer: Chief Business Officer. This Robb Gary Charles insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Corcept Therapeutics Incorporated (CORT). Investors use Robb Gary Charles's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Corcept Therapeutics IncorporatedCORT$1.8M25.7k sharesGrant / ExerciseJun 2, 2026$25.2K358 shares$70.44--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Corcept Therapeutics IncorporatedCORT--26k sharesGrant / ExerciseJun 1, 2026Disclosure amount unavailable776 shares----
Corcept Therapeutics IncorporatedCORT$1.8M25.3k sharesGrant / ExerciseJun 1, 2026$54.7K776 shares$70.44--
Corcept Therapeutics IncorporatedCORT--12.6k sharesGrant / ExerciseMay 13, 2026Disclosure amount unavailable1k shares----
Corcept Therapeutics IncorporatedCORT--24.5k sharesGrant / ExerciseMay 13, 2026Disclosure amount unavailable5.3k shares----
Corcept Therapeutics IncorporatedCORT$2.9M79.5k sharesGrant / ExerciseMar 3, 2026$4.4K121 shares$35.97--
Corcept Therapeutics IncorporatedCORT--79.6k sharesGrant / ExerciseMar 2, 2026Disclosure amount unavailable499 shares----
Corcept Therapeutics IncorporatedCORT$2.8M79.1k sharesGrant / ExerciseMar 2, 2026$17.9K499 shares$35.97--
Corcept Therapeutics IncorporatedCORT$5.0M140k sharesGrant / ExerciseFeb 27, 2026$5.0M140k shares$35.70--
Corcept Therapeutics IncorporatedCORT$6.6M78.6k sharesGrant / ExerciseDec 24, 2025$6.7M80.3k shares$83.59--
Corcept Therapeutics IncorporatedCORT$0145k sharesGrant / ExerciseDec 24, 2025$562.6K145k shares$3.88--
Corcept Therapeutics IncorporatedCORT$1.1M13.9k sharesGrant / ExerciseDec 2, 2025$11.8K148 shares$79.78--
Corcept Therapeutics IncorporatedCORT--14.1k sharesGrant / ExerciseDec 1, 2025Disclosure amount unavailable224 shares----
Corcept Therapeutics IncorporatedCORT$1.1M13.8k sharesGrant / ExerciseDec 1, 2025$17.9K224 shares$79.78--
Corcept Therapeutics IncorporatedCORT$971k13.6k sharesGrant / ExerciseSep 3, 2025$18.3K256 shares$71.38--
Corcept Therapeutics IncorporatedCORT--13.9k sharesGrant / ExerciseSep 2, 2025Disclosure amount unavailable251 shares----
Corcept Therapeutics IncorporatedCORT$972k13.6k sharesGrant / ExerciseSep 2, 2025$17.9K251 shares$71.38--
Corcept Therapeutics IncorporatedCORT$951k13.4k sharesGrant / ExerciseAug 22, 2025$190.3K2.7k shares$71.17--
Corcept Therapeutics IncorporatedCORT$1.1M16k sharesSellAug 22, 2025$165.8K2.3k shares$71.27--
Corcept Therapeutics IncorporatedCORT$71k18.4k sharesGrant / ExerciseAug 22, 2025$19.4K5k shares$3.88--
Corcept Therapeutics IncorporatedCORT$946k13.4k sharesSellJun 16, 2025$225.4K3.2k shares$70.77--